Literature DB >> 21196939

A role for dihydrotestosterone treatment in older men?

Mara Y Roth1, Stephanie T Page.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21196939      PMCID： PMC3192006          DOI： 10.1038/aja.2010.173

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  11 in total

1.  Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.

Authors:  Amanda Idan; Kaye A Griffiths; D Tim Harwood; Markus J Seibel; Leo Turner; Ann J Conway; David J Handelsman
Journal:  Ann Intern Med       Date:  2010-11-16       Impact factor: 25.391

Review 2.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

3.  The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

Authors:  J D McConnell; R Bruskewitz; P Walsh; G Andriole; M Lieber; H L Holtgrewe; P Albertsen; C G Roehrborn; J C Nickel; D Z Wang; A M Taylor; J Waldstreicher
Journal:  N Engl J Med       Date:  1998-02-26       Impact factor: 91.245

4.  An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.

Authors:  Zhang Weihua; Richard Lathe; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

5.  A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.

Authors:  L P Ly; M Jimenez; T N Zhuang; D S Celermajer; A J Conway; D J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

6.  The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.

Authors:  Pekka Kunelius; Olavi Lukkarinen; Minna L Hannuksela; Outi Itkonen; Juha S Tapanainen
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.

Authors:  Henry A Feldman; Christopher Longcope; Carol A Derby; Catherine B Johannes; Andre B Araujo; Andrea D Coviello; William J Bremner; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.

Authors:  C Wang; A Iranmanesh; N Berman; V McDonald; B Steiner; F Ziel; S M Faulkner; R E Dudley; J D Veldhuis; R S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

9.  Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.

Authors:  Richard A Anderson; A Michael Wallace; Naveed Sattar; Narendar Kumar; Kalyan Sundaram
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men.

Authors:  C J Bagatell; R H Knopp; J E Rivier; W J Bremner
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.